Results 271 to 280 of about 291,450 (306)

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

Lancet, The, 2021
Sumanta K Pal, Catherine Tangen, Naomi B Haas   +2 more
exaly  

Papillary Carcinoma

2000
James Oertel, Yolanda Oertel
openaire   +2 more sources

Cabozantinib: a new first-line option for papillary renal cell carcinoma?

Lancet, The, 2021
Delphine Borchiellini
exaly  

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

New England Journal of Medicine, 2023
Sandro S Santagata, Evanthia Galanis, Priscilla K Brastianos   +2 more
exaly  

Papillary Carcinoma

2017
Luis Requena, Omar Sangüeza
openaire   +1 more source

Multifocal Papillary Thyroid Carcinoma

American Journal of Clinical Pathology, 2021
openaire   +2 more sources

Papillary Renal-Cell Carcinoma

New England Journal of Medicine, 2016
W Marston, Linehan, Maria J, Merino, Christopher J, Ricketts   +2 more
openaire   +3 more sources

Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident

Science, 2021
Lindsay M Morton, Danielle M Karyadi, Chip Stewart   +2 more
exaly  

Papillary Carcinoma

2006
Yolanda C. Oertel, James E. Oertel
openaire   +1 more source

Tall Cell Papillary Carcinoma

The American Journal of Surgical Pathology, 1989
M, Sobrinho-Simões, C, Sambade, J M, Nesland, J V, Johannessen   +3 more
openaire   +2 more sources